​

Funding Round

Series A - Georgiamune

Series A - Georgiamune

Investment Firm

Overview

Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.

Announced Date

Aug 09, 2023

Closed on Date

Aug 09, 2023

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

General Catalyst

General Catalyst

General Catalyst is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

6

Investor Name
Participant InvestorAlexandria Venture Investments
Participant InvestorMubadala Capital Ventures
Participant InvestorCatalio Capital Management
Participant InvestorBioventures Investors
Participant InvestorGeneral Catalyst

Round Details and Background

Georgiamune raised $75000000 on 2023-08-09 in Series A

Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 01, 2019
Venture Round - Georgiamune
1-undefined
Aug 09, 2023
Series A - Georgiamune
7-75.0M

Recent Activity

There is no recent news or activity for this profile.